Notice2023-19398
Advisory Council on Blood Stem Cell Transplantation
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 8, 2023
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary's Advisory Council on Blood Stem Cell Transplantation (ACBSCT or Advisory Council) has scheduled public meetings. Information about the Advisory Council and the agenda for these meetings can be found on the ACBSCT website at: https:// bloodstemcell.hrsa.gov/about/advisory-council.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 173 (Friday, September 8, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 173 (Friday, September 8, 2023)]
[Notices]
[Page 62097]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-19398]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Council on Blood Stem Cell Transplantation
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's Advisory Council on Blood Stem
Cell Transplantation (ACBSCT or Advisory Council) has scheduled public
meetings. Information about the Advisory Council and the agenda for
these meetings can be found on the ACBSCT website at: <a href="https://bloodstemcell.hrsa.gov/about/advisory-council">https://bloodstemcell.hrsa.gov/about/advisory-council</a>.
DATES: Thursday, September 28, 2023, 2:00 p.m.-6:00 p.m. Eastern
Standard Time; and Thursday, October 26, 2023, 2:00 p.m.-6:00 p.m.
Eastern Standard Time.
ADDRESSES: Both meetings will be held virtually by webinar. A link to
register and join each meeting will be posted at least 10 days prior to
the meeting date at: <a href="https://bloodstemcell.hrsa.gov/about/advisory-council">https://bloodstemcell.hrsa.gov/about/advisory-council</a>.
FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant, Designated Federal
Official, at the HRSA Health Systems Bureau, Division of
Transplantation, 5600 Fishers Lane, 8W-67, Rockville, MD 20857; 301-
443-8036; or <a href="/cdn-cgi/l/email-protection#f5b4b6b7a6b6a1bda7a6b4b59d878694db929a83"><span class="__cf_email__" data-cfemail="eeafadacbdadbaa6bcbdafae869c9d8fc0898198">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Advisory Council provides advice and
recommendations to the Secretary of Health and Human Services on
policy, program development, and other matters of significance
concerning the activities under the authority of 42 U.S.C. 274k
(section 379 of the Public Health Service Act), as amended, and Public
Law 109-129, as amended. The Advisory Council may transmit its
recommendations through the Administrator of HRSA on matters related to
the activities of the C.W. Bill Young Cell Transplantation Program and
National Cord Blood Inventory.
The agenda for the September 28, 2023, meeting is being finalized
and may include the following topics: the Department of Health and
Human Services' periodic review of the state of the science of using
adult stem cells and birthing tissues to develop new types of therapies
for patients, for the purpose of considering potential inclusion of
such new therapies in the C.W. Bill Young Cell Transplantation Program;
criteria for defining a high-quality cord blood unit for banking
specifications; the unmet needs in blood stem cell transplantation and
cellular therapy; strategies to improve rates of donation for adult
blood stem cell donors; and other areas to increase blood stem cell
donation and transplantation. The agenda for the October 26, 2023,
meeting will be determined based on discussion, priorities, and/or
action items from the September 28, 2023 meeting. All agenda items will
be posted on the Advisory Council's website no later than 10 days prior
to the respective meeting dates. Agenda items are subject to change as
priorities dictate. Refer to the Advisory Council's website for any
updated information concerning the meeting. Members of the public will
have the opportunity to provide comments. Public participants may
submit written statements in advance of the scheduled meetings; oral
comments will be honored in the order they are requested and may be
limited as time allows. Requests to submit a written statement or make
oral comments to the Advisory Council should be sent to Shelley Tims
Grant, using the contact information above at least 3 business days
prior to the meeting. Individuals who plan to attend and need special
assistance or other reasonable accommodations should notify the
Advisory Council at the address and phone number listed above at least
10 business days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-19398 Filed 9-7-23; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 8, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.